Return On Equity of Kalaris Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kalaris Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Kalaris Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -290%, a 258% decline year-over-year.
  • Kalaris Therapeutics, Inc. annual Return On Equity for 2024 was 82%.
  • Kalaris Therapeutics, Inc. annual Return On Equity for 2023 was -133%, a 63% decline from 2022.
  • Kalaris Therapeutics, Inc. annual Return On Equity for 2022 was -82%, a 33% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Kalaris Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -290% -473% -258% 01 Jul 2025 30 Sep 2025
Q2 2025 413% +1295% 01 Apr 2025 30 Jun 2025
Q1 2025 151% +335% 01 Jan 2025 31 Mar 2025
Q4 2024 82% +215% 01 Oct 2024 31 Dec 2024
Q3 2024 183% +263% 01 Jul 2024 30 Sep 2024
Q2 2024 -882% -808% -1091% 01 Apr 2024 30 Jun 2024
Q1 2024 -184% -104% -130% 01 Jan 2024 31 Mar 2024
Q4 2023 -133% -51% -63% 01 Oct 2023 31 Dec 2023
Q3 2023 -80% +11% +12% 01 Jul 2023 30 Sep 2023
Q2 2023 -74% +17% +19% 01 Apr 2023 30 Jun 2023
Q1 2023 -80% -5% -6.8% 01 Jan 2023 31 Mar 2023
Q4 2022 -82% -20% -33% 01 Oct 2022 31 Dec 2022
Q3 2022 -91% -47% -105% 01 Jul 2022 30 Sep 2022
Q2 2022 -91% -57% -164% 01 Apr 2022 30 Jun 2022
Q1 2022 -75% -38% -102% 01 Jan 2022 31 Mar 2022
Q4 2021 -61% -14% -30% 01 Oct 2021 31 Dec 2021
Q3 2021 -44% +67% +60% 01 Jul 2021 30 Sep 2021
Q2 2021 -35% -100% -153% 01 Apr 2021 30 Jun 2021
Q1 2021 -37% -101% -158% 01 Jan 2021 31 Mar 2021
Q4 2020 -47% -105% -181% 01 Oct 2020 31 Dec 2020
Q3 2020 -112% 01 Jul 2020 30 Sep 2020
Q2 2020 65% 01 Apr 2020 30 Jun 2020
Q1 2020 64% 01 Jan 2020 31 Mar 2020
Q4 2019 58% 01 Oct 2019 31 Dec 2019

Kalaris Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 82% +215% 01 Jan 2024 31 Dec 2024
2023 -133% -51% -63% 01 Jan 2023 31 Dec 2023
2022 -82% -20% -33% 01 Jan 2022 31 Dec 2022
2021 -61% -14% -30% 01 Jan 2021 31 Dec 2021
2020 -47% -105% -181% 01 Jan 2020 31 Dec 2020
2019 58% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.